Duration of Androgen Suppression in the Treatment of Prostate Cancer
M. Bolla(Centre Hospitalier Universitaire de Grenoble), Laurence Collette(GlaxoSmithKline (Belgium)), Oleg B. Kariakine(Medical Radiological Research Center), Eliahu Gez(Rambam Health Care Campus), Elsbietha M. van der Steen-Banasik, Philip Poortmans(University of Antwerp), Theodorus M. de Reijke(Amsterdam UMC Location University of Amsterdam), Geertjan van Tienhoven, A. Akdaş(Marmara University), M. Piérart(Unknown), Alphonsus C. M. van den Bergh(University Medical Center Groningen), P. Kil(Elisabeth-TweeSteden Ziekenhuis), Guy Soete(Universitair Ziekenhuis Brussel), Jorg R. Oddens(Amsterdam University Medical Centers), Murielle Mauer(Heidelberg University), E. Musat(European Organisation for Research and Treatment of Cancer)
Cited by 966
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k